EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS
The aim of this study was to identify the most effective (in the clinical and pharmacoeconomic aspects) drug for the treatment of widespread progressing differentiated thyroid cancer (DTC) refractory to radioactive iodine in patients – residents of the Russian Federation.Materials and Methods. The b...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
IRBIS LLC
2017-05-01
|
| Серія: | Фармакоэкономика |
| Предмети: | |
| Онлайн доступ: | https://www.pharmacoeconomics.ru/jour/article/view/177 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|